CollPlant Biotechnologies (CLGN) Payables (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Payables of $635000.0 for Q1 2026, down 17.53% on a YoY basis from $770000.0 in Q1 2025, and up 4.1% quarter-over-quarter from $610000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Payables (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Payables for 10 years, with the latest figure at $635000.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 17.53% year-over-year to $635000.0; the trailing twelve-month figure through Mar 2026 stood at $635000.0 (down 17.53% YoY), and the FY2025 full-year result was $610000.0, down 29.89% from the prior year.
- Payables for Q1 2026 stood at $635000.0, up from $610000.0 in the prior quarter.
- The five-year high for Payables was $1.1 million in Q2 2024, with the low at $571000.0 in Q2 2025.
- Historically, Payables has averaged $852235.3 across 5 years, with a median of $870000.0 in 2024.
- Annual changes were most pronounced in 2024 — Payables soared 49.15% — and 2025, when it sank 49.82%.
- CollPlant Biotechnologies' Payables stood at $1.1 million in 2022, then declined by 13.5% to $980000.0 in 2023, then dropped by 11.22% to $870000.0 in 2024, then dropped by 29.89% to $610000.0 in 2025, then rose by 4.1% to $635000.0 in 2026.
- The last three Payables figures came in at $635000.0 (Q1 2026), $610000.0 (Q4 2025), and $618000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 635,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 635,000.00 |
| Dec 31, 2025 | 610,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 770,000.00 |
| Dec 31, 2024 | 870,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 980,000.00 |
| Sep 30, 2023 | 744,000.00 |
| Jun 30, 2023 | 763,000.00 |
| Mar 31, 2023 | 885,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 880,000.00 |
| Jun 30, 2022 | 760,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 865,000.00 |
| Jun 30, 2021 | 698,000.00 |